|
|
||||||||||
|
J Am Coll Cardiol, 1999; 34:1413-1419 © 1999 by the American College of Cardiology Foundation |
a Department of Cardiology, Cardiothoracic Center, University Hospital, Uppsala, Sweden
Manuscript received January 5, 1999; revised manuscript received June 8, 1999, accepted June 30, 1999.
Reprint requests and correspondence: Tomas Jernberg, Department of Cardiology, Cardiothoracic Center, University Hospital, 751 85 Uppsala, Sweden
tomas.jernberg{at}medicin.uu.se
OBJECTIVES
The purpose of this study was to evaluate the prognostic importance of ischemic episodes detected by ST-segment monitoring with continuous 12-lead electrocardiography (ECG) in a nonselected coronary care unit (CCU) population with chest pain and ECG nondiagnostic of acute myocardial infarction (AMI).
BACKGROUND
Patients with chest pain and ECG nondiagnostic of AMI constitute a heterogeneous group concerning both diagnosis and prognosis. Continuous 12-lead ECG is a rather new method not thoroughly studied in this population.
METHODS
The ST-segment monitoring with continuous 12-lead ECG was performed for 12 h in 630 consecutive patients admitted to CCU due to chest pain and a nondiagnostic ECG, i.e., no ST-segment elevations. An ST-episode was defined as a transient ST-segment depression or elevation of at least 0.10 mV. The median follow-up time was six months.
RESULTS
A total of 176 ST-episodes occurred in 100 (15.9%) patients. The median duration and maximal ST-segment deviation in patients with ST-episodes were 80 min and 0.20 mV, respectively. Presence of ST-episodes predicted worse outcome concerning cardiac death and cardiac death or myocardial infarction (MI) (log-rank p < 0.001). At 30 day follow-up procedure, 10% versus 1.5% died from cardiac causes or had an MI in the group with and without ST-episodes, respectively. In a multivariate analysis, only troponin T
0.10 µg/l and the presence of ST-episodes came out as independent predictors of cardiac death or MI.
CONCLUSIONS
Continuous 12-lead ECG monitoring provides prognostic information on-line and considerably improves early risk stratification in patients with ECG nondiagnostic of AMI and symptoms suggestive of acute coronary syndrome.
| ||||||||||||||||||
This article has been cited by other articles:
![]() |
R.L. Soiza, S.J. Leslie, P. Williamson, S. Wai, K. Harrild, N.R. Peden, and A.D. Hargreaves Risk stratification in acute coronary syndromes--does the TIMI risk score work in unselected cases? QJM, February 1, 2006; 99(2): 81 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Lagerqvist, E Diderholm, B Lindahl, S Husted, F Kontny, E Stahle, E Swahn, P Venge, A Siegbahn, and L Wallentin FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease Heart, August 1, 2005; 91(8): 1047 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. Cohn, K. M. Fox, and C. Daly Silent Myocardial Ischemia Circulation, September 9, 2003; 108(10): 1263 - 1277. [Full Text] [PDF] |
||||
![]() |
T. Jernberg, M. Stridsberg, P. Venge, and B. Lindahl N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation J. Am. Coll. Cardiol., August 7, 2002; 40(3): 437 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jernberg, P. Abrahamsson, B. Lindahl, P. Johanson, L. Wallentin, and M. Dellborg Continuous multilead ST-monitoring identifies patients with unstable coronary artery disease who benefit from extended antithrombotic treatment Eur. Heart J., July 2, 2002; 23(14): 1093 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jernberg, B. Lindahl, and L. Wallentin Continuous multilead ST-segment monitoring should be a part of the clinical routine Eur. Heart J., June 2, 2002; 23(12): 918 - 921. [Full Text] [PDF] |
||||
![]() |
K.M. Akkerhuis, P.A.J. Klootwijk, W. Lindeboom, V.A.W.M. Umans, S. Meij, P.-P. Kint, and M.L. Simoons Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients Eur. Heart J., November 1, 2001; 22(21): 1997 - 2006. [Abstract] [PDF] |
||||
![]() |
S.-F. Wung Computer-Assisted Continuous ST-Segment Analysis for Clinical Research: Methodological Issues Biol Res Nurs, October 1, 2001; 3(2): 65 - 77. [Abstract] [PDF] |
||||
![]() |
E.M. Antman, R. Corbalan, K. Huber, and A.S. Jaffe Issues in early risk stratification for UA/NSTEMI Eur. Heart J. Suppl., August 1, 2001; 3(suppl_J): J6 - J14. [Abstract] [PDF] |
||||
![]() |
D. Fitchett, S. Goodman, and A. Langer New advances in the management of acute coronary syndromes: 1. Matching treatment to risk Can. Med. Assoc. J., May 1, 2001; 164(9): 1309 - 1316. [Full Text] [PDF] |
||||
![]() |
B. Lindahl, H. Toss, A. Siegbahn, P. Venge, L. Wallentin, and The FRISC Study Group Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery Disease N. Engl. J. Med., October 19, 2000; 343(16): 1139 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ambrosio and S. Mandorla Chest pain and a non-diagnostic ECG: trying not to be frustrated Eur. Heart J., September 1, 2000; 21(17): 1403 - 1405. [PDF] |
||||
![]() |
T Jernberg, B Lindahl, and L Wallentin The combination of a continuous 12-lead ECG and troponin T. A valuable tool for risk stratification during the first 6 hours in patients with chest pain and a non-diagnostic ECG Eur. Heart J., September 1, 2000; 21(17): 1464 - 1472. [Abstract] [PDF] |
||||
![]() |
Using ST-Segment Monitoring to Predict Cardiac Events Journal Watch Emergency Medicine, January 1, 2000; 2000(101): 16 - 16. [Full Text] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |